# FDA Inspection 1305074 - American National Red Cross, The - February 24, 2026

Source: https://www.keypedia.com/records/fda_inspections/american-national-red-cross-the/14554c4e-646d-4c4b-8d9d-93d1f9be22c3
Source feed: FDA_Inspections

> FDA Inspection 1305074 for American National Red Cross, The on February 24, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1305074
- Company Name: American National Red Cross, The
- Inspection Date: 2026-02-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1305074 - 2026-02-24](https://www.keypedia.com/records/fda_inspections/american-national-red-cross-the/0edf9edd-7c36-47a3-a86a-49309633097f)
- [FDA Inspection 1101361 - 2019-08-01](https://www.keypedia.com/records/fda_inspections/american-national-red-cross-the/16792138-12f7-4cd6-acb5-c3db57690bf5)
- [FDA Inspection 919533 - 2015-02-27](https://www.keypedia.com/records/fda_inspections/american-national-red-cross-the/403bf02e-bcac-4349-b6d6-1759eaae58f1)
- [FDA Inspection 836192 - 2013-03-15](https://www.keypedia.com/records/fda_inspections/american-national-red-cross-the/ece868ca-15e0-4254-9602-6f7cd57deaa1)
- [FDA Inspection 793832 - 2012-08-03](https://www.keypedia.com/records/fda_inspections/american-national-red-cross-the/111623bb-bce1-422f-bb51-98db03ecffb5)

Company: https://www.keypedia.com/companies/american-national-red-cross-the/d1f30957-9e54-45f3-8e12-d6f61472c1f3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d